The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Change in Survival in Metastatic Breast Cancer with Treatment Advances: Meta-Analysis and Systematic Review
Open accessAbstract
Background: Metastatic breast cancer (MBC) treatment has changed substantially over time, but we do not know whether survival post-metastasis has improved at the population level. Methods: We searched for studies of MBC patients that reported survival after metastasis in at least two time periods between 1970 and the present. We used meta-regression models to test for survival improvement over time in four disease groups: recurrent, recurrent estrogen (ER)-positive, recurrent ER-negative, and de novo stage IV. We performed sensitivity analyses based on bias in some studies that could lead earlier cohorts to include more aggressive cancers. Results: There were 15 studies of recurrent MBC (N = 18 678 patients; 3073 ER-positive and 1239 ER-negative); meta-regression showed no survival improvement among patients recurring between 1980 and 1990, but median survival increased from 21 (95% confidence interval [CI] = 18 to 25) months to 38 (95% CI = 31 to 47) months from 1990 to 2010. For ER-positive MBC patients, median survival increased during 1990–2010 from 32 (95% CI = 23 to 43) to 57 (95% CI = 37 to 87) months, and for ER-negative MBC patients from 14 (95% CI = 11 to 19) to 33 (95% CI = 21 to 51) months. Among eight studies (N = 35 831) of de novo stage IV MBC, median survival increased during 1990–2010 from 20 (95% CI = 16 to 24) to 31 (95% CI = 24 to 39) months. Results did not change in sensitivity analyses. Conclusion: By bridging studies over time, we demonstrated improvements in survival for recurrent and de novo stage IV MBC overall and across ER-defined subtypes since 1990. These results can inform patient-doctor discussions about MBC prognosis and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Berry, D. A., Cronin, K. A., Plevritis, S. K., Fryback, D. G., Clarke, L., Zelen, M., Mandelblatt, J. S., Yakovlev, A. Y., Habbema, J. D. F., & Feuer, E. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050518 · Cited by 2,460
Self-citationImproved tests for a random effects meta‐regression with a single covariate
Knapp, G., & Hartung, J. (2003) · Statistics in Medicine · doi:10.1002/sim.1482 · Cited by 2,075 · cited 1×
“For each case, we performed random-effects metaregression analysis (46) assuming an underlying mixed effect model that predicted median overall survival based on the year of recurrence (Supplemental Methods, available online).”
MethodMONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancer
Goetz, M. P., Toi, M., Campone, M., Sohn, J., Paluch-Shimon, S., Huober, J., Park, I. H., Trédan, O., Chen, S.-C., Manso, L., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.75.6155 · Cited by 1,744
Sledge, G. W., Toi, M., Neven, P., Sohn, J., Inoue, K., Pivot, X., Burdaeva, O., Okera, M., Masuda, N., Kaufman, P. A., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.7585 · Cited by 1,680
Self-citationAnnual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival
Jemal, A., Ward, E. M., Johnson, C. J., Cronin, K. A., Ma, J., Ryerson, A. B., Mariotto, A., Lake, A. J., Wilson, R., Sherman, R. L., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djx030 · Cited by 1,556
Global cancer in women: burden and trends.
Torre, L. A., Islami, F., Siegel, R. L., Ward, E. M., & Jemal, A. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0858 · Cited by 1,245
Cortes, J., O'Shaughnessy, J., Loesch, D., Blum, J. L., Vahdat, L. T., Petrakova, K., Chollet, P., Manikas, A., Diéras, V., Delozier, T., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60070-6 · Cited by 1,094
O’Shaughnessy, J., Miles, D., Vukelja, S., Moiseyenko, V., Ayoub, J.-P., Cervantes, G., Fumoleau, P., Jones, S., Lui, W.-Y., Mauriac, L., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.09.002 · Cited by 1,081
Swain, S. M., Kim, S.-B., Cortés, J., Ro, J., Semiglazov, V., Campone, M., Ciruelos, E., Ferrero, J.-M., Schneeweiss, A., Knott, A., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70130-x · Cited by 1,006
The Decrease in Breast-Cancer Incidence in 2003 in the United States
Ravdin, P. M., Cronin, K. A., Howlader, N., Berg, C. D., Chlebowski, R. T., Feuer, E. J., Edwards, B. K., & Berry, D. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmsr070105 · Cited by 982
Perez, E. A., Romond, E. H., Suman, V. J., Jeong, J.-H., Davidson, N. E., Geyer, C. E., Martino, S., Mamounas, E. P., Kaufman, P. A., & Wolmark, N. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.0868 · Cited by 717
Diéras, V., Miles, D., Verma, S., Pegram, M., Welslau, M., Baselga, J., Krop, I. E., Blackwell, K., Hoersch, S., Xu, J., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30312-1 · Cited by 667
Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer
Jones, S. E., Erban, J., Overmoyer, B., Budd, G. T., Hutchins, L., Lower, E., Laufman, L., Sundaram, S., Urba, W. J., Pritchard, K. I., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.027 · Cited by 547
Giordano, S. H., Buzdar, A. U., Smith, T. L., Kau, S., Yang, Y., & Hortobagyi, G. N. (2004) · Cancer · doi:10.1002/cncr.11859 · Cited by 540
NCCN Guidelines Insights: Breast Cancer, Version 1.2017
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2017) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2017.0044 · Cited by 529
Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States
Mariotto, A. B., Etzioni, R., Hurlbert, M., Penberthy, L., & Mayer, M. (2017) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-0889 · Cited by 529
Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast Cancer
Mauri, D., Polyzos, N. P., Salanti, G., Pavlidis, N., & Ioannidis, J. P. A. (2008) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djn414 · Cited by 523
Nabholtz, J.-M., Senn, H. J., Bezwoda, W. R., Melnychuk, D., Deschênes, L., Douma, J., Vandenberg, T. A., Rapoport, B., Rosso, R., Trillet-Lenoir, V., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1413 · Cited by 508
Chia, S. K., Speers, C. H., D'yachkova, Y., Kang, A., Malfair‐Taylor, S., Barnett, J., Coldman, A., Gelmon, K. A., O'Reilly, S. E., & Olivotto, I. A. (2007) · Cancer · doi:10.1002/cncr.22867 · Cited by 465
Albain, K. S., Nag, S. M., Calderillo-Ruiz, G., Jordaan, J. P., Llombart, A. C., Pluzanska, A., Rolski, J., Melemed, A. S., Reyes-Vidal, J. M., Sekhon, J. S., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.9362 · Cited by 425
Breast Cancer With Synchronous Metastases: Trends in Survival During a 14-Year Period
Andre, F., Slimane, K., Bachelot, T., Dunant, A., Namer, M., Barrelier, A., Kabbaj, O., Spano, J. P., Marsiglia, H., Rouzier, R., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.095 · Cited by 394
Rapiti, E., Verkooijen, H. M., Vlastos, G., Fioretta, G., Neyroud-Caspar, I., Sappino, A. P., Chappuis, P. O., & Bouchardy, C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2226 · Cited by 391
Prognostic factors in 1038 women with metastatic breast cancer
Largillier, R., Ferrero, J.-M., Doyen, J., Barriere, J., Namer, M., Mari, V., Courdi, A., Hannoun-Levi, J. M., Ettore, F., Birtwisle-Peyrottes, I., et al. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn424 · Cited by 373
Plevritis, S. K., Munoz, D., Kurian, A. W., Stout, N. K., Alagoz, O., Near, A. M., Lee, S. J., van den Broek, J. J., Huang, X., Schechter, C. B., et al. (2018) · JAMA · doi:10.1001/jama.2017.19130 · Cited by 302
Self-citationGennari, A., Conte, P., Rosso, R., Orlandini, C., & Bruzzi, P. (2005) · Cancer · doi:10.1002/cncr.21359 · Cited by 280
Survival differences among women with de novo stage IV and relapsed breast cancer
Dawood, S., Broglio, K., Ensor, J., Hortobagyi, G. N., & Giordano, S. H. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq220 · Cited by 273
Aromatase inhibitors for treatment of advanced breast cancer in postmenopausal women
Gibson, L., Lawrence, D., Dawson, C., & Bliss, J. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003370.pub3 · Cited by 252
Ellis, M. J., Llombart-Cussac, A., Feltl, D., Dewar, J. A., Jasiówka, M., Hewson, N., Rukazenkov, Y., & Robertson, J. F. R. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.5831 · Cited by 238
Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial
Aebi, S., Gelber, S., Anderson, S. J., Láng, I., Robidoux, A., Martín, M., Nortier, J. W. R., Paterson, A. H. G., Rimawi, M. F., Cañada, J. M. B., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70589-8 · Cited by 209
Tevaarwerk, A. J., Gray, R. J., Schneider, B. P., Smith, M. L., Wagner, L. I., Fetting, J. H., Davidson, N., Goldstein, L. J., Miller, K. D., & Sparano, J. A. (2013) · Cancer · doi:10.1002/cncr.27819 · Cited by 196
Improved survival in metastatic breast cancer 1985-2016
Sundquist, M., Brudin, L., & Tejler, G. (2017) · The Breast · doi:10.1016/j.breast.2016.10.005 · Cited by 188
Dawood, S., Broglio, K., Gonzalez-Angulo, A. M., Buzdar, A. U., Hortobagyi, G. N., & Giordano, S. H. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1168 · Cited by 187
Stockler, M. R., Harvey, V. J., Francis, P. A., Byrne, M., Ackland, S. P., Fitzharris, B. M., van Hazel, G., Wilcken, N. R. C., Grimison, P., Nowak, A. K., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.9101 · Cited by 150
Effects of Screening and Systemic Adjuvant Therapy on ER-Specific US Breast Cancer Mortality
Muñoz, D. F., Near, A. M., van Ravesteyn, N. T., Lee, S. J., Schechter, C. B., Alagöz, O., Berry, D. A., Burnside, E. S., Chang, Y.-J., Chisholm, G. B., et al. (2014) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dju289 · Cited by 146
Self-citationHassett, M. J., Ritzwoller, D. P., Taback, N., Carroll, N. M., Cronin, A. M., Ting, G. V., Schrag, D., Warren, J. L., Hornbrook, M. C., & Weeks, J. C. (2012) · Medical Care · doi:10.1097/mlr.0b013e318277eb6f · Cited by 126
Chubak, J., Yu, O., Pocobelli, G. S., Lamerato, L. E., Webster, J., Prout, M. N., Yood, M. U., Barlow, W. E., & Buist, D. S. M. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs233 · Cited by 124
Identifying Cancer Relapse Using SEER-Medicare Data
Earle, C. C., Nattinger, A. B., Potosky, A. L., Lang, K. M., Mallick, R., Berger, M. S., & Warren, J. L. (2002) · Medical Care · doi:10.1097/00005650-200208001-00011 · Cited by 118
Whyte, J. L., Engel-Nitz, N. M., Teitelbaum, A. H., Rey, G. G., & Kallich, J. D. (2013) · Medical Care · doi:10.1097/mlr.0b013e318289c3fb · Cited by 108
Fifteen-year trends in metastatic breast cancer survival in Greece
Dafni, U. G., Grimani, I., Xyrafas, A., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0630-8 · Cited by 86
Identification of metastatic cancer in claims data
Nordstrom, B. L., Whyte, J. L., Stolar, M. J., Mercaldi, C. J., & Kallich, J. D. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3247 · Cited by 84
Mowat, F. S., Lau, Whyte, Kelsh, Legg, Engel-Nitz, Watson, Collins, & Nordyke, R. J. (2011) · Clinical Epidemiology · doi:10.2147/clep.s23690 · Cited by 75
Foukakis, T., Fornander, T., Lekberg, T., Hellborg, H., Adolfsson, J., & Bergh, J. C. S. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1594-z · Cited by 73
Ruiterkamp, J., Ernst, M. F., de Munck, L., der Loo, M. V. D. H., Bastiaannet, E., van de Poll-Franse, L. V., Bosscha, K. P., Tjan‐Heijnen, V. C. G., & Voogd, A. C. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1349-x · Cited by 68
Occurrence and outcome of de novo metastatic breast cancer by subtype in a large, diverse population
Li, T., Chu, L. K., Wang, L. I., Moy, L. M., Brammer, M. G., Song, C., Green, M. C., Kurian, A. W., Gomez, S. L., & Clarke, C. A. (2016) · Cancer Causes & Control · doi:10.1007/s10552-016-0791-9 · Cited by 60
Self-citationWeide, R., Feiten, S., Friesenhahn, V., Heymanns, J., Kleboth, K., Thomalla, J., van Roye, C., & Köppler, H. (2014) · SpringerPlus · doi:10.1186/2193-1801-3-535 · Cited by 47
Trends in breast cancer survival in Germany from 1976 to 2008—A period analysis by age and stage
Holleczek, B., Arndt, V., Stegmaier, C., & Brenner, H. (2011) · Cancer Epidemiology · doi:10.1016/j.canep.2011.01.008 · Cited by 45
Meglio, A. D., Freedman, R. A., Lin, N., Barry, W. T., Metzger, O., Keating, N. L., King, T. A., Sertoli, M. R., Boccardo, F., Winer, E. P., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3845-5 · Cited by 42
Rogoz, B., de l’Aulnoit, A. H., Duhamel, A., & de l’Aulnoit, D. H. (2017) · Clinical Breast Cancer · doi:10.1016/j.clbc.2017.08.012 · Cited by 37
Pavlík, T., Májek, O., Büchler, T., Vyzula, R., Petera, J., Ryska, M., Ryška, A., Cibula, D., Babjuk, M. M., Abrahámová, J., et al. (2013) · Cancer Epidemiology · doi:10.1016/j.canep.2013.11.002 · Cited by 27
Shigematsu, H., Kawaguchi, H., Nakamura, Y., Tanaka, K., Shiotani, S., Koga, C., Nishimura, S., Taguchi, K., Nishiyama, K., & Ohno, S. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-118 · Cited by 22
Pal, S. K., Dehaven, M. E., Nelson, R. A., Onami, S. H., Hsu, J., Waliany, S., Kruper, L. L., & Mortimer, J. E. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-435 · Cited by 20
Ribociclib for HR-Positive, Advanced Breast Cancer
Gramont, A. D. E., Herrera, A., & de Gramont, A. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1615255 · Cited by 20
Survival time according to the year of recurrence and subtype in recurrent breast cancer
Nakano, M., Fujisue, M., Tashima, R., Okumura, Y., Nishiyama, Y., Ohsako, T., Toyozumi, Y., Arima, N., & Nishimura, R. (2015) · The Breast · doi:10.1016/j.breast.2015.06.003 · Cited by 17
Trends in Survival for Patients with Metastatic Breast Cancer: Is Survival Improving?
Giuliani, J., & Bonetti, A. (2015) · Tumori Journal · doi:10.5301/tj.5000301 · Cited by 16
Disparities in the survival improvement of recurrent breast cancer
Anan, K., Mitsuyama, S., Koga, K., Tanabe, R., Saimura, M., Tanabe, Y., Watanabe, M., Suehara, N., Matsunaga, H., Nishihara, K., et al. (2009) · Breast Cancer · doi:10.1007/s12282-009-0103-2 · Cited by 15
Cited by
Breast cancer statistics, 2019
DeSantis, C. E., Ma, J., Gaudet, M. M., Newman, L. A., Miller, K. D., Goding Sauer, A., Jemal, A., & Siegel, R. L. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21583 · Cited by 3,114
Gennari, A., André, F., Barrios, C. H., Cortés, J., de Azambuja, E., DeMichele, A., Dent, R., Fenlon, D., Gligorov, J., Hurvitz, S. A., et al. (2021) · Annals of Oncology · doi:10.1016/j.annonc.2021.09.019 · Cited by 1,417
Ganesh, K., & Massagué, J. (2021) · Nature Medicine · doi:10.1038/s41591-020-01195-4 · Cited by 1,051
The lingering mysteries of metastatic recurrence in breast cancer
Riggio, A. I., Varley, K. E., & Welm, A. L. (2021) · British Journal of Cancer · doi:10.1038/s41416-020-01161-4 · Cited by 616
Triple‑negative breast cancer therapy: Current and future perspectives (Review)
Won, K., & Spruck, C. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.5135 · Cited by 527
Metadata
- Authors
- Caswell-Jin, J. L., Plevritis, S. K., Tian, L., Cadham, C. J., Xu, C., Stout, N. K., Sledge, G. W., Mandelblatt, J. S., & Kurian, A. W.
- Venue
- JNCI Cancer Spectrum
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-10-01
- Volume
- 2
- Issue
- 4
- Pages
- pky062-pky062
- ISSN
- 2515-5091 (ISSN-L)
- OpenAlex
- W2905887518
- Cited by
- 315
- References
- 57
- FWCI
- 2.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.